References
- Davison AJ, Scott JE. The complete DNA sequence of varicella-zoster virus. J Gen Virol 1986;67(Pt 9):1759-816. https://doi.org/10.1099/0022-1317-67-9-1759
- Schmidt-Chanasit J, Sauerbrei A. Evolution and worldwide distribution of varicella-zoster virus clades. Infect Genet Evol 2011;11:1-10. https://doi.org/10.1016/j.meegid.2010.08.014
- Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW, Zhang JX, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002;287:606-11. https://doi.org/10.1001/jama.287.5.606
- Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974;2:1288-90.
- Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med 2005;352:450-8. https://doi.org/10.1056/NEJMoa042271
- Oh SH. Update in varicella vaccination. Korean J Pediatr 2006;49:229-34. https://doi.org/10.3345/kjp.2006.49.3.229
- Choi EH. Varicella vaccination: worldwide status and provisional updated recommendation in Korea. Korean J Pediatr Infect Dis 2008:15;11-8.
- Park SJ, Song HJ, Kim CW, Lee KS. A clinical study of 72 cases of herpes zoster in children and adolescents. Korean J Dermatol 2006;44:664-8.
- Seo PS, Yoon NH, Park SD. A clinical study of chicken pox in adolescents and adults. Korean J Dermatol 2005;43:933-8.
- Lee GH, Lee SH, Lee SY, Lee JS, Whang KU. A clinical study of chickenpox in adult inpatients. Korean J Dermatol 2010;48:272-7.
- Park CK, Kim HO, Park CW, Lee CH. The effect of active immunization on the clinical courses of varicella. Korean J Dermatol 2008;46:1011-9.
- Loparev VN, Rubtcova E, Seward JF, Levin MJ, Schmid DS. DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine. J Infect Dis 2007;195:502-10. https://doi.org/10.1086/510532
- Loparev VN, Gonzalez A, Deleon-Carnes M, Tipples G, Fickenscher H, Torfason EG, et al. Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping. J Virol 2004;78:8349-58. https://doi.org/10.1128/JVI.78.15.8349-8358.2004
- Carapetis JR, Russell DM, Curtis N. The burden and cost of hospitalised varicella and zoster in Australian children. Vaccine 2004;23:755-61. https://doi.org/10.1016/j.vaccine.2004.07.025
- Marshall HS, McIntyre P, Richmond P, Buttery JP, Royle JA, Gold MS, et al. Changes in patterns of hospitalized children with varicella and of associated varicella genotypes following introduction of varicella vaccine in Australia. Pediatr Infect Dis J 2013;32:530-7. https://doi.org/10.1097/INF.0b013e31827e92b7
- van Lier A, van der Maas NA, Rodenburg GD, Sanders EA, de Melker HE. Hospitalization due to varicella in the Netherlands. BMC Infect Dis 2011;11:85. https://doi.org/10.1186/1471-2334-11-85
- Kim SH, Lee HJ, Park SE, Oh SH, Lee SY, Choi EH. Seroprevalence rate after one dose of varicella vaccine in infants. J Infect 2010;61:66-72. https://doi.org/10.1016/j.jinf.2010.04.001
- Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis 2004;4:26-33. https://doi.org/10.1016/S1473-3099(03)00857-0
- Nagasawa K, Yamauchi Y, Tada Y, Kusaba T, Niho Y, Yoshikawa H. High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis. Ann Rheum Dis 1990;49:630-3. https://doi.org/10.1136/ard.49.8.630
- Morens DM, Bregman DJ, West CM, Greene MH, Mazur MH, Dolin R, et al. An outbreak of varicella-zoster virus infection among cancer patients. Ann Intern Med 1980;93:414-9. https://doi.org/10.7326/0003-4819-93-3-414
- Adler AL, Casper C, Boeckh M, Heath J, Zerr DM. An outbreak of varicella with likely breakthrough disease in a population of pediatric cancer patients. Infect Control Hosp Epidemiol 2008;29:866-70. https://doi.org/10.1086/590358
- Folatre I, Zolezzi P, Schmidt D, Marin F, Tager M. Infections caused by varicella zoster virus in children with cancer aged less than 15 years old. Rev Med Chil 2003;131:759-64.
- Arvin AM. Antiviral therapy for varicella and herpes zoster. Semin Pediatr Infect Dis 2002;13:12-21. https://doi.org/10.1053/spid.2002.29753
- Prober CG, Kirk LE, Keeney RE. Acyclovir therapy of chickenpox in immunosuppressed children--a collaborative study. J Pediatr 1982;101:622-5. https://doi.org/10.1016/S0022-3476(82)80725-7
- Nyerges G, Meszner Z, Gyarmati E, Kerpel-Fronius S. Acyclovir prevents dissemination of varicella in immunocompromised children. J Infect Dis 1988;157:309-13. https://doi.org/10.1093/infdis/157.2.309
- Novelli VM, Marshall WC, Yeo J, McKendrick GD. Acyclovir administered perorally in immunocompromised children with varicella-zoster infections. J Infect Dis 1984;149:478. https://doi.org/10.1093/infdis/149.3.478
- Meszner Z, Nyerges G, Bell AR. Oral acyclovir to prevent dissemination of varicella in immunocompromised children. J Infect 1993;26:9-15. https://doi.org/10.1016/0163-4453(93)96648-A
- Jain Y, Lodha R, Tomar S, Arya LS, Kabra SK. Oral acyclovir in varicella zoster virus infections in children with acute lymphoblastic leukemia. Indian Pediatr 2000;37:1239-41.
- Carcao MD, Lau RC, Gupta A, Huerter H, Koren G, King SM. Sequential use of intravenous and oral acyclovir in the therapy of varicella in immunocompromised children. Pediatr Infect Dis J 1998;17:626-31. https://doi.org/10.1097/00006454-199807000-00010
- Bomgaars L, Thompson P, Berg S, Serabe B, Aleksic A, Blaney S. Valacyclovir and acyclovir pharmacokinetics in immunocompromised children. Pediatr Blood Cancer 2008;51:504-8. https://doi.org/10.1002/pbc.21638
- Eksborg S, Pal N, Kalin M, Palm C, Soderhall S. Pharmacokinetics of acyclovir in immunocompromized children with leukopenia and mucositis after chemotherapy: can intravenous acyclovir be substituted by oral valacyclovir?Med Pediatr Oncol 2002;38:240-6. https://doi.org/10.1002/mpo.1317